Research and Markets (http://www.researchandmarkets.com/research/7035ab/infectious_disease) has announced the addition of the "Infectious Disease Testing Market: US, Europe, Japan--Emerging Opportunities and Business Strategies" report to their offering.
The infectious disease testing market is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers in the 21st century. Among the main driving forces behind the growth of this dynamic market is continuous spread of AIDS, which remains the world's major health threat and a major factor contributing to the rise in incidence of opportunistic infections; bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs
Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products
This comprehensive worldwide survey is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies. The report provides a market segmentation analysis of over 70 diseases and viruses in seven countries, assessment of emerging technologies, review of current instrumentation, as well as strategic profiles of leading suppliers and recent market entrants with innovative technologies and products
"The Infectious Disease Testing Market: Emerging Opportunities and Business Expansion Strategies" is Venture Planning Group's seven-country survey designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies. The report includes the market segmentation analysis of over 70 diseases and viruses in seven countries, assessment of emerging technologies, review of current instrumentation, as well as strategic profiles of leading suppliers and recent market entrants with innovative technologies and products.
The infectious disease testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers. Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and diagnostic technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.
The study is based on a combination of primary and secondary sources of information, including interviews with executives from major diagnostics companies and start-up firms developing innovative products, laboratory directors, experts from industry associations, and the investment banking community; comprehensive review of the most recent technical and business publications, manufacturer product literature, patents, trade association surveys, government studies, marketing and technical meeting presentation, industry analyst reports; as well as Venture Planning Group's proprietary data files.
This two-volume report contains over 2,000 pages, 800 tables, and presents the following information:
Market Segmentation Analysis